STOCK TITAN

Director Witney Frank lists ALMR stock option holdings in Form 3

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Alamar Biosciences director Witney Frank has reported existing stock option holdings for Class B Common Stock. The filing lists three option awards with exercise prices of $0.59, $3.10 and $7.60 per share, covering 49,627, 33,085 and 124,069 underlying shares, expiring between 2031 and 2036.

Footnotes state that one option is fully vested, while others vest in monthly installments over 48 months, with a portion beginning to vest on January 15, 2027 and another measured from January 1, 2025, contingent on continuous service.

Positive

  • None.

Negative

  • None.
Insider Witney Frank
Role null
Type Security Shares Price Value
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
holding Stock Option (Right to Buy) -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 124,069 shares (Direct, null)
Footnotes (1)
  1. Twenty-five percent of the shares subject to the option vest on 1/15/2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date. Fully vested. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
Option 1 exercise price $3.10 per share Stock Option (Right to Buy) on Class B Common Stock
Option 1 underlying shares 33,085 shares Underlying Class B Common Stock at $3.10 exercise price
Option 2 exercise price $0.59 per share Stock Option (Right to Buy) on Class B Common Stock
Option 2 underlying shares 49,627 shares Underlying Class B Common Stock at $0.59 exercise price
Option 3 exercise price $7.60 per share Stock Option (Right to Buy) on Class B Common Stock
Option 3 underlying shares 124,069 shares Underlying Class B Common Stock at $7.60 exercise price
Earliest option expiration April 20, 2031 Expiration date of one stock option grant
Latest option expiration January 14, 2036 Expiration date of another stock option grant
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for each derivative entry"
Class B Common Stock financial
"underlying_security_title: "Class B Common Stock" associated with each option"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
vest financial
"1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
fully vested financial
"Footnote stating: "Fully vested.""
continuous service financial
"subject to the reporting person's continuous service through each such vesting date"
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Witney Frank

(Last)(First)(Middle)
C/O ALAMAR BIOSCIENCES, INC.
47071 BAYSIDE PARKWAY

(Street)
FREMONT CALIFORNIA 94538

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
04/16/2026
3. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy) (1)01/14/2036Class B Common Stock124,069$7.6D
Stock Option (Right to Buy) (2)04/20/2031Class B Common Stock49,627$0.59D
Stock Option (Right to Buy) (3)04/15/2035Class B Common Stock33,085$3.1D
Explanation of Responses:
1. Twenty-five percent of the shares subject to the option vest on 1/15/2027, and 1/48th of the shares vest monthly thereafter, subject to the reporting person's continuous service through each such vesting date.
2. Fully vested.
3. The shares subject to the option vest in equal monthly installments over 48 months measured from January 1, 2025, subject to the reporting person's continuous service as of each such vesting date.
/s/ Justin J. McAnear, Attorney-in-Fact04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Alamar Biosciences (ALMR) Form 3 for Witney Frank show?

The Form 3 shows director Witney Frank’s existing stock option holdings in Alamar Biosciences. It lists three stock option awards on Class B Common Stock with specified exercise prices, share amounts, expiration dates, and detailed vesting schedules tied to continued service.

How many Alamar Biosciences (ALMR) shares are covered by Witney Frank’s options?

Witney Frank’s options cover three blocks of underlying shares: 49,627, 33,085 and 124,069 shares of Class B Common Stock. Each block is tied to a separate stock option with its own exercise price, vesting terms, and expiration date disclosed in the filing.

What are the exercise prices of Witney Frank’s Alamar Biosciences (ALMR) options?

The filing discloses exercise prices of $0.59, $3.10 and $7.60 per share for three stock option grants. Each option relates to Class B Common Stock and has distinct expiration dates ranging from 2031 through 2036, as reported in the derivative holdings table.

When do Witney Frank’s Alamar Biosciences (ALMR) options expire?

The options expire on April 20, 2031, April 15, 2035 and January 14, 2036. Each expiration date corresponds to a different option with its own exercise price and underlying share count, indicating long-dated equity incentives tied to continued service.

How do Witney Frank’s Alamar Biosciences (ALMR) options vest?

One option is described as fully vested. Another vests 25% on January 15, 2027 with 1/48th monthly thereafter, and a third vests in equal monthly installments over 48 months from January 1, 2025, all requiring continuous service at each vesting date.

Does the Alamar Biosciences (ALMR) Form 3 show recent insider buying or selling?

No recent buying or selling activity is identified in this Form 3. The entries are coded as holdings of stock options, with transaction direction classified as unknown and transaction counts for buys, sells, and exercises all reported as zero in the summary section.